Latest filing published 26 Dec 2019 for Dianthus Therapeutics, Inc. /DE/, €64k.
Filing timeline
BuySaleInsider track record
Christina K. Isacson: trading record in brief
Christina K. Isacson discloses dealings in Dianthus Therapeutics, Inc. /DE/ to SEC (Form 4). Between 25 June 2018 and 24 December 2019, the trades on record add up to 4 filings.
No open-market purchase appears, only 3 sales worth €284k. Since January 2019: no purchases and 3 sales on the market.
Most recently, on 26 December 2019, the filings show an open-market sale worth €64k in Dianthus Therapeutics, Inc. /DE/. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christina K. Isacson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,463 shares@ US$16.0122.7% of flowCommon StockSEC:0001562180-19-006266:0
- 9,867 shares@ US$16.0350.2% of flowCommon StockSEC:0001562180-19-006260:0
- 5,415 shares@ US$16.0727.1% of flowCommon StockSEC:0001562180-19-003624:0
- 2,912 sharesCommon StockSEC:0000899243-18-018331:0
4 of 4 declarations
